USPTO 2015–2025 USPTO PatentsView US Corporation

Sonde Health, Inc.

USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding).

RSS updates for this company

The verdict

According to USPTO PatentsView, Sonde ranks #43,219 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.

#43,219
of 49,997 US assignees by volume
25th percentile
by Innovation Score (27.9/100)
18.0
avg claims per patent
+400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R43219 · US Corporation #43,219 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 6 grants
  • LOWER-Q #43,219/49,997
  • PHOTO-FINISH Somavac Medical…
  • CPC-NARROW G10L · 4 areas
  • INNOV-THIN 27.9/100
  • CLAIMS-RICH 18.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +400% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Somavac Medical Solutions, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Sonde

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Sonde's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Sonde's grants concentrate

Sonde Health, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2019. By volume, Sonde sits between Somavac Medical Solutions, Inc. and Soshin Electric Co., Ltd..

Sonde's three-year grant acceleration

Sonde Health, Inc. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Sonde's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Sonde holds 6 patents at rank #43,306, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Sonde

By rank, the assignees closest to #43,306 in granted patent volume.

Leaders in G10L (Speech Analysis Techniques OR Speech Synthesis)

Other assignees with the most granted patents in Sonde's primary technology class.

Sonde's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 20192020202120232024 1
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Sonde Health, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 16.7%
2020 1 16.7%
2021 2 33.3%
2023 1 16.7%
2024 1 16.7%

Where it ranks

Overall rank by patents

#43,219

of 49,997 tracked assignees

Innovation Score

27.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Sonde Health, Inc.'s patent record in context - here's where to go next.

  • Sonde Health, Inc.'s lead technology class is G10L (Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding), 100% of its portfolio - see every assignee active in that class. Explore G10L
  • Ranked #43,219 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Sonde Health, Inc. against Somavac Medical Solutions, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.